GSK plc GSK.L
GSK plc statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (£11.30); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
GSK plc trades at about 1337.5× earnings — near its 10-year norm (10-year range 388.7×–2258.8×, median 1351.9×).
Shaded band = 10-year range (388.7×–2258.8×); dot = today's 1337.5×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 72.4% | 71.2% | 71.8% | 67.4% |
| Operating margin | 25.5% | 17.7% | 24.2% | 22.9% |
| Net margin | 17.5% | 8.2% | 16.2% | 51.0% |
| FCF margin | 14.6% | 11.4% | 14.6% | 17.5% |
| Return on assets | 9.4% | 4.3% | 8.4% | 24.9% |
| Return on equity | 34.9% | 18.8% | 36.9% | 141.1% |
| Debt / equity | 0.86× | 1.00× | 1.06× | 1.53× |
| Current ratio | 0.82 | 0.78 | 0.88 | 0.91 |
Computed from company filings · GB · as of 2025-12-31. Figures in GBP. Facts plus Stocktoria's own computed scores — not investment advice.